X4 Pharmaceuticals Inc (XFOR) financials · rev $6.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
X4 Pharmaceuticals Inc (XFOR) rev $6.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $6.50M | $2.60M |
| Cost of Revenue | $5.76M | $797.0K |
| Gross Profit | $743.0K | $1.80M |
| Operating Income | -$86.9M | -$36.4M |
| Net Income | -$79.2M | -$37.5M |
| EPS (Diluted) | -$1.87 | -$0.19 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $290.5M | $146.4M |
| Current Assets | $261.6M | $112.2M |
| Cash & Equivalents | $217.0M | $55.7M |
| Inventory | N/A | $2.82M |
| PP&E | $182.0K | $776.0K |
| Total Liabilities | $104.2M | $124.3M |
| Current Liabilities | $25.8M | $32.9M |
| Long-term Debt | $75.0M | $75.0M |
| Total Debt | $75.0M† | $75.0M† |
| Shareholders' Equity | $186.3M | $22.1M |
| Retained Earnings | -$594.6M | -$515.4M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$85.6M | -$130.9M |
| CapEx | N/A | $326.0K |
| Investing Cash Flow | $8.15M | $67.0M |
| Financing Cash Flow | $238.6M | $20.3M |
| Net Change in Cash | $161.4M | -$43.8M |
| Free Cash Flow | -$85.6M | -$131.2M |
FAQ
What is XFOR P/E and revenue?
X4 Pharmaceuticals Inc (XFOR) rev $6.5M.
What is XFOR revenue?
X4 Pharmaceuticals Inc last cached revenue is $6.50M (FY2025).
Is XFOR profitable?
X4 Pharmaceuticals Inc last cached net income is -$79.2M (FY2025).
What are XFOR total assets?
X4 Pharmaceuticals Inc last cached total assets are $290.5M (FY2025).
What is XFOR free cash flow?
X4 Pharmaceuticals Inc last cached free cash flow is -$85.6M (FY2025).
Not investment advice. Cached statements, not a live tape.